Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;31:D31-42. https://doi.org/10.1016/j.vaccine.2013.05.012.
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15–20. https://doi.org/10.1056/NEJM200001063420103.
Article CAS PubMed Google Scholar
Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S, Heath PT. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547–56. https://doi.org/10.1016/S0140-6736(11)61651-6.
Puopolo KM, Lynfield R, Cummings JJ, Hand I, Adams-Chapman I, Poindexter B, Stewart DL, Aucott SW, Goldsmith JP, Mowitz M, Watterberg K, Maldonado YA, Zaoutis TE, Banerjee R, Barnett ED, Campbell JD, Gerber JS, Kourtis AP, Munoz FM, Nolt D, Nyquist AC, O’Leary ST, Sawyer MH, Steinbach WJ, Zangwill K, Committee on fetus and newborn, Committee on infectious diseases. Management of infants at risk for group B Streptococcal disease. Pediatrics. 2019;144:e20191881. https://doi.org/10.1542/peds.2019-1881.
Lohrmann F, Hufnagel M, Kunze M, Afshar B, Creti R, Detcheva A, Kozakova J, Rodriguez-Granger J, Sørensen UBS, Margarit I, Maione D, Rinaudo D, Orefici G, Telford J, de la Rosa FM, Kilian M, Efstratiou A, Berner R, Melin P. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study. Infection. 2023;51:981–91. https://doi.org/10.1007/s15010-022-01965-x.
Article CAS PubMed Google Scholar
Schrag SJ, Verani J. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013. https://doi.org/10.1016/j.vaccine.2012.11.056.
ACOG (American Congress of Obstetricians and Gynecologists) Committee on Obstetric Practice. ACOG committee opinion no 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117:1019–27. https://doi.org/10.1097/AOG.0b013e318219229b. PMID: 31977793.
Verani M JR, L S, S.J. (2010) Division of bacterial diseases, national center for immunization and respiratory diseases, centers for disease control and prevention (CDC. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC 59:1–36
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revis Guidel CDC Morb Mort Wkly Rep Recomm Rep. 2002;51:1–22.
Hughes RG, Brocklehurst P, Steer PJ, Heath P. Stenson BM on behalf of the royal college of obstetricians and gynaecologists prevention of early-onset neonatal group B streptococcal disease. Green-top Guidel. 2017. https://doi.org/10.1111/1471-0528.14821.
Kunze M, Ziegler A, Fluegge K, Hentschel R, Proempeler H, Berner R. Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single university center in Germany. J Perinat Med. 2011;39:417–22. https://doi.org/10.1515/jpm.2011.037.
Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis. 2012;31:2097–104. https://doi.org/10.1007/s10096-012-1559-0.
Article CAS PubMed Google Scholar
Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014;14:1083–9. https://doi.org/10.1016/S1473-3099(14)70919-3.
Russell NJ, Seale AC, O’Sullivan C, Le Doare K, Heath PT, Lawn JE, Bartlett L, Cutland C, Gravett M, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Baker CJ. Risk of early-onset neonatal group b streptococcal disease with maternal colonization worldwide systematic review meta-analyses. Clin Infect Dis. 2017;65:S152–9. https://doi.org/10.1093/cid/cix655.
Article PubMed PubMed Central Google Scholar
Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M. Prevention of group B streptococcal neonatal disease revisited DEVANI European project. Eur J Clin Microbiol Infect Dis. 2012;31:2097–104. https://doi.org/10.1007/s10096-012-1559-0.
Article CAS PubMed Google Scholar
Fabbrini M, Rigat F, Rinaudo CD, Passalaqua I, Khacheh S, Creti R, Baldassarri L, Carboni F, Anderloni G, Rosini R, Maione D, Grandi G, Telford JL, Margarit I. The protective value of maternal group B Streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera. Clin Infect Dis. 2016;63:746–53. https://doi.org/10.1093/cid/ciw377.
Article CAS PubMed Google Scholar
Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, Sørensen UBS, Telford J, Valinsky L, Zachariadou L, Efstratiou A, Members of the DEVANI Study Group. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (group B streptococci). J Clin Microbiol. 2011;49:1475–82.
Article CAS PubMed PubMed Central Google Scholar
Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, Sørensen UBS, Kilian M, Members of the DEVANI Study Group. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol. 2013;51:503–7. https://doi.org/10.1128/JCM.02417-12.
Article CAS PubMed PubMed Central Google Scholar
Rosini R, Campisi E, De Chiara M, Tettelin H, Rinaudo D, Toniolo C, Metruccio M, Guidotti S, Sørensen UBS, Kilian M, Ramirez M, Janulczyk R, Donati C, Grandi G, Margarit I, DEVANI Consortium. Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population. PLoS ONE. 2015;10:e0125985. https://doi.org/10.1371/journal.pone.0125985.
Article CAS PubMed PubMed Central Google Scholar
Lohrmann F, Berg A, Wicker E, Imm A, Krause G, Zürn K, Berner R, Hufnagel M, Lander F. Prevalence of capsular serotype, Pilus Island distribution, and antibiotic resistance in pediatric and adult invasive Group B Streptococcus isolates: data from a nationwide prospective surveillance study in Germany. Pediatr Infect Dis J. 2021;40:76–82. https://doi.org/10.1097/INF.0000000000002943.
Creti R, Imperi M, Berardi A, Pataracchia M, Recchia S, Alfarone G, Baldassarri L, Italian Neonatal GBS Infections Working Group. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance. Pediatr Infect Dis J. 2017;36:256–62. https://doi.org/10.1097/INF.0000000000001414.
Absalon J, Segall N, Block SL, Center KJ, Scully IL, Giardina PC, Peterson J, Watson WJ, Gruber WC, Jansen KU, Peng Y, Munson S, Pavliakova D, Scott DA, Anderson AS. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. Lancet Infect Dis. 2021;21:263–74. https://doi.org/10.1016/S1473-3099(20)30478-3.
Article CAS PubMed Google Scholar
Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21:3468–72. https://doi.org/10.1016/s0264-410x(03)00353-0.
Article CAS PubMed Google Scholar
Swamy GK, Metz TD, Edwards KM, Soper DE, Beigi RH, Campbell JD, Grassano L, Buffi G, Dreisbach A, Margarit I, Karsten A, Henry O, Lattanzi M, Bebia Z. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: results from a randomized placebo-controlled phase II trial. Vaccine. 2020;38:6930–40. https://doi.org/10.1016/j.vaccine.2020.08.056.
Article CAS PubMed Google Scholar
Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, Kwatra G, Ramsamy Y, Said M, Jones S, Jose L, Fairlie L, Barnabas SL, Newton R, Munson S, Jefferies Z, Pavliakova D, Silmon de Monerri NC, Gomme E, Perez JL, Scott DA, Gruber WC, Jansen KU. Potential for maternally administered vaccine for infant group B streptococcus. N Engl J Med. 2023;389:215–27. https://doi.org/10.1056/NEJMoa2116045.
Article CAS PubMed Google Scholar
Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80:212–4. https://doi.org/10.1016/j.mimet.2009.11.010.
Article CAS PubMed Google Scholar
Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion summary, Number 797. Obstet Gynecol. 2020;135(2):489–492. https://doi.org/10.1097/AOG.0000000000003669.
Madrid L, Seale AC,
Comments (0)